Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

NRG Oncology names vice chairs and committee members

NRG Oncology announced changes in leadership across multiple committees.

August 14, 2026

Michelle Ozbun named associate director for basic research at UNMCCC

Michelle Ozbun was appointed associate director for basic research of the University of New Mexico Comprehensive Cancer Center.

August 14, 2026

Vol.52 No.32

In Brief

Alastair Thompson to lead IU’s breast cancer center

Alastair Thompson was named director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s Vera Bradley Foundation Center for Breast Cancer Research.

August 07, 2026

Vol.52 No.31

In Brief

UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy

Cristina Puig-Saus, an associate professor of microbiology, immunology and molecular genetics and surgical oncology at the David Geffen School of Medicine at UCLA and an investigator at the UCLA Health Jonsson Comprehensive Cancer Center, and her research team have received a five-year, $3.9 million grant from NCI to develop drug-based strategies that could enhance cancer immunotherapy for patients with melanoma and potentially other types of cancer.

August 07, 2026

Vol.52 No.31

In Brief

Dana-Farber Department of Pathology receives $2.8M grant from NCI

Dana-Farber Cancer Institute’s Department of Pathology, in collaboration with Brigham and Women’s Hospital, has received renewed funding for the Ruth L. Kirschstein NRSA Institutional Research Training Grant from the NCI, providing resources for pathology residents, clinical fellows, and PhD-trained scientists pursuing research careers in cancer pathology.

August 07, 2026

Vol.52 No.31

Cancer History Project

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

If a Mount Rushmore of Epidemiology were to exist, Joseph F. Fraumeni Jr. would be etched into the face of the mountain, former NCI Director Ned Sharpless once told Stephen J. Chanock.

July 31, 2026

Vol.52 No.30

By Sara Willa Ernst

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

YOU MAY BE INTERESTED IN

NRG Oncology names vice chairs and committee members

Michelle Ozbun named associate director for basic research at UNMCCC

Alastair Thompson to lead IU’s breast cancer center

UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy

Dana-Farber Department of Pathology receives $2.8M grant from NCI

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor

Renew today!

Subscriber content

Never miss an issue!

Login

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

YOU MAY BE INTERESTED IN

NRG Oncology names vice chairs and committee members

Michelle Ozbun named associate director for basic research at UNMCCC

Alastair Thompson to lead IU’s breast cancer center

UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy

Dana-Farber Department of Pathology receives $2.8M grant from NCI

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”Chanock and Brawley reflect on their illustrious mentor

Never miss an issue!

Login

Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”
Chanock and Brawley reflect on their illustrious mentor